BGC Group (BGC) Q4 2025 earnings review
Record Revenues Mask Margin Compression
BGC delivered a massive top-line beat with Q4 revenue up 32% to a record $756.4M, driven by the OTC acquisition and FMX market share gains. However, this growth came at a cost: Adjusted EBITDA margins compressed significantly (from ~33.5% to ~25.2%) and GAAP Net Income fell 43% due to $54.8M in cost-reduction charges. While the FMX platform is a juggernaut—hitting 39% US Treasury market share—the company is currently digesting the lower-margin OTC business. Guidance for 26Q1 is aggressive, projecting ~34% YoY revenue growth, suggesting management sees the integration headwinds as temporary.
🐂 Bull Case
FMX is rapidly taking share from incumbents. US Treasury market share hit a record 39% (up from 30% a year ago), and FMX Futures volumes exploded (+82% QoQ). This is high-quality, organic growth.
The Energy, Commodities, and Shipping (ECS) segment grew 92% YoY to $257.5M. BGC is now the world's largest energy broker, providing massive cross-selling opportunities.
🐻 Bear Case
Despite 32% revenue growth, Adjusted EBITDA actually declined 0.8% YoY. The acquired OTC business appears to be structurally lower margin, and integration costs are weighing heavily on profitability.
GAAP Net Income collapsed 43% to just $13.9M. The company excluded $54.8M in 'cost reduction program' charges from Adjusted figures, creating a wide divergence between reported and adjusted profitability.
⚖️ Verdict: 🟢
Bullish. The margin compression is ugly but likely transitory as they integrate OTC. The top-line momentum (32% growth) and the structural breakout of the FMX platform (39% market share) are too strong to ignore. The guidance for 26Q1 (+34% revenue growth) confirms the growth story is accelerating, not stalling.
Key Themes
FMX: The Treasury Juggernaut
FMX continues to disrupt the US Treasury market. Market share reached a record 39% in Q4, up from 37% in Q3 and 30% a year ago. FMX Futures Exchange saw average daily volume (ADV) soar 82% sequentially from Q3. This is no longer a 'potential' disruptor; it is actively taking volume from the incumbent monopoly.
Margin Dilution from OTC
The OTC acquisition has boosted revenue but hurt margins. Adjusted EBITDA margin fell from 33.5% in 24Q4 to 25.2% in 25Q4. Management explicitly noted Adjusted EBITDA was lower due to charges related to the cost reduction program. The company needs to prove it can raise OTC margins to the corporate average.
ECS Segment Explosion
Energy, Commodities, and Shipping (ECS) revenue nearly doubled (+92%) to $257.5M. Even excluding the OTC acquisition, organic growth was 10.0%. This segment has transformed from a secondary business into a primary growth engine, now larger than the Rates business ($197.4M).
Cost Reduction Charges
BGC incurred $54.8M in charges related to its cost reduction program in Q4, with a cash impact of $28.1M. While these are labeled 'non-recurring' and excluded from Adjusted Earnings, they heavily impacted GAAP results and cash flow. Management promises $25M in annualized savings in 2026, but the upfront cost was steep.
Broad-Based Organic Growth
The growth story isn't just M&A. Excluding OTC, revenues still grew 12.2%. Rates (+16.4%), Equities (+29.0%), and Fenics Growth Platforms (+18.9% ex-Capitalab) all showed strong double-digit organic expansion, benefiting from global volatility.
Other KPIs
Stagnant (-0.8% YoY). This is the key weak spot in the report. Despite adding $184M in revenue YoY, EBITDA actually fell slightly, highlighting the lower margin profile of acquired assets and integration friction.
Accelerating. Up 15.4% YoY. This high-margin electronic segment continues to compound, driven by Fenics Markets (+15.1%) and Lucera (+24.1%).
Reversing. Down 42.6% YoY. EPS fell from $0.05 to $0.03. This metric bore the brunt of the $54.8M cost reduction charge.
Guidance
Accelerating. The midpoint ($890M) implies ~34% YoY growth vs the $664.2M reported in 25Q1. This indicates that the momentum from Q4 (32% growth) is continuing into the new year.
Accelerating. Midpoint ($212M) implies ~32% growth vs 25Q1 ($160.2M). This suggests that margins may begin to stabilize or expand slightly sequentially as cost savings kick in.
Key Questions
EBITDA Margin Stabilization
Adjusted EBITDA margins compressed significantly this quarter despite record revenue. When do you expect the 'low teens' margin profile of the OTC business to converge with the corporate average, and is the $25M savings target sufficient to close that gap?
Cash Cost of Restructuring
You incurred a $28.1M cash impact from cost reduction charges in Q4. Should we expect further significant cash outlays for integration in 2026, or is the heavy lifting complete?
FMX Monetization Curve
With 39% market share in UST and soaring Futures volumes, when does FMX become a material contributor to EBITDA margin expansion rather than just a revenue driver?